Mackay Shields LLC’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-35,700
Closed -$2.51M 751
2021
Q1
$2.51M Sell
35,700
-28,700
-45% -$1.65M 0.02% 676
2020
Q4
$2.75M Sell
64,400
-28,200
-30% -$1.07M 0.02% 707
2020
Q3
$2.88M Sell
92,600
-28,100
-23% -$875K 0.02% 630
2020
Q2
$3.2M Buy
120,700
+10,900
+10% +$234K 0.03% 553
2020
Q1
$1.92M Sell
109,800
-8,300
-7% -$191K 0.02% 685
2019
Q4
$3.26M Buy
118,100
+41,900
+55% +$1.21M 0.02% 675
2019
Q3
$2.32M Buy
+76,200
New +$2.19M 0.01% 847
2019
Q2
Sell
-41,093
Closed -$1.26M 1406
2019
Q1
$1.26M Buy
41,093
+400
+1% +$14.4K 0.01% 915
2018
Q4
$1.39M Sell
40,693
-24,707
-38% -$957K 0.01% 805
2018
Q3
$3.17M Sell
65,400
-17,000
-21% -$798K 0.02% 571
2018
Q2
$3.77M Sell
82,400
-50,600
-38% -$2.08M 0.03% 564
2018
Q1
$4.26M Buy
+133,000
New +$4.63M 0.03% 538

Other funds holding ARCB

Mackay Shields LLC's ARCB Position: Q2 2021 in Review

Mackay Shields LLC sold out of ArcBest (ARCB) in Q2 2021, closing a stake of 35,700 shares — an estimated $2.51M sold.

Mackay Shields LLC first reported a position in ARCB in Q1 2018 and held it in 12 quarters. The position peaked at $4.26M in Q1 2018. 214 funds tracked by Wall St. Rank hold ARCB as of Q2 2021.

  • Mackay Shields LLC reported no remaining ArcBest position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 35,700 ArcBest shares in Q2 2021, an estimated $2.51M.
  • Mackay Shields LLC first reported a position in ArcBest in Q1 2018 and held it in 12 quarters.
  • Mackay Shields LLC's ArcBest position peaked at $4.26M in Q1 2018.
  • 214 funds tracked by Wall St. Rank held ArcBest as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.